Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Calcium-Sensing | 167 | 2015 | 320 | 12.720 |
Why?
|
Calcium | 271 | 2015 | 5781 | 7.860 |
Why?
|
Parathyroid Glands | 152 | 2009 | 522 | 7.660 |
Why?
|
Receptors, Cell Surface | 108 | 2003 | 2815 | 5.390 |
Why?
|
Parathyroid Hormone | 149 | 2013 | 1791 | 4.770 |
Why?
|
Hypercalcemia | 57 | 2015 | 425 | 3.450 |
Why?
|
Calcium-Binding Proteins | 38 | 2003 | 1077 | 2.580 |
Why?
|
Hyperparathyroidism | 56 | 2012 | 338 | 2.370 |
Why?
|
Extracellular Space | 36 | 2009 | 562 | 1.900 |
Why?
|
Calcium Signaling | 20 | 2014 | 736 | 1.700 |
Why?
|
Hypocalcemia | 24 | 2014 | 205 | 1.600 |
Why?
|
Mitogen-Activated Protein Kinases | 15 | 2012 | 1243 | 1.410 |
Why?
|
Homeostasis | 42 | 2015 | 3341 | 1.380 |
Why?
|
Kidney | 49 | 2013 | 7071 | 1.290 |
Why?
|
Calcium Channels | 18 | 2007 | 622 | 1.220 |
Why?
|
Cattle | 95 | 2006 | 3814 | 1.190 |
Why?
|
Osteoblasts | 13 | 2013 | 1143 | 1.190 |
Why?
|
Cyclic AMP | 59 | 1994 | 1472 | 1.180 |
Why?
|
Magnesium | 28 | 2013 | 815 | 1.040 |
Why?
|
Potassium Channels | 10 | 2001 | 534 | 0.960 |
Why?
|
Autoantibodies | 12 | 2013 | 2115 | 0.940 |
Why?
|
Parathyroid Hormone-Related Protein | 15 | 2013 | 327 | 0.850 |
Why?
|
Calcium Metabolism Disorders | 6 | 2007 | 11 | 0.840 |
Why?
|
Inositol Phosphates | 18 | 2014 | 175 | 0.760 |
Why?
|
Hypoparathyroidism | 13 | 2009 | 136 | 0.750 |
Why?
|
Astrocytoma | 7 | 2004 | 773 | 0.740 |
Why?
|
Hepatocyte Growth Factor | 5 | 2004 | 268 | 0.740 |
Why?
|
Protein Kinase C | 14 | 2010 | 1206 | 0.700 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 7 | 2005 | 478 | 0.690 |
Why?
|
Animals | 254 | 2015 | 168887 | 0.680 |
Why?
|
Neomycin | 12 | 2000 | 94 | 0.650 |
Why?
|
Amino Acids | 7 | 2009 | 1711 | 0.650 |
Why?
|
Parathyroid Neoplasms | 18 | 2003 | 244 | 0.620 |
Why?
|
Bone and Bones | 10 | 2013 | 2559 | 0.580 |
Why?
|
Blotting, Northern | 22 | 2005 | 1549 | 0.580 |
Why?
|
Phosphorus | 5 | 2012 | 336 | 0.560 |
Why?
|
GTP-Binding Proteins | 14 | 2003 | 946 | 0.530 |
Why?
|
Cytosol | 26 | 2002 | 886 | 0.510 |
Why?
|
RNA, Messenger | 49 | 2013 | 12788 | 0.500 |
Why?
|
Calcitonin | 7 | 2013 | 326 | 0.500 |
Why?
|
Autoimmune Diseases | 5 | 2013 | 2249 | 0.450 |
Why?
|
Blotting, Western | 24 | 2014 | 5021 | 0.440 |
Why?
|
Organometallic Compounds | 3 | 2008 | 646 | 0.440 |
Why?
|
Cell Division | 18 | 2004 | 4474 | 0.440 |
Why?
|
Cell Line | 41 | 2009 | 15563 | 0.430 |
Why?
|
Signal Transduction | 27 | 2015 | 23611 | 0.430 |
Why?
|
Rats | 53 | 2007 | 23718 | 0.420 |
Why?
|
Caveolins | 3 | 2003 | 102 | 0.420 |
Why?
|
Thiophenes | 3 | 2008 | 570 | 0.420 |
Why?
|
Cations, Divalent | 15 | 1999 | 167 | 0.410 |
Why?
|
Bone Development | 3 | 2013 | 470 | 0.400 |
Why?
|
Cloning, Molecular | 23 | 2001 | 4167 | 0.400 |
Why?
|
Leydig Cell Tumor | 4 | 2005 | 28 | 0.390 |
Why?
|
Peptide Hormones | 2 | 2003 | 133 | 0.390 |
Why?
|
Chemotaxis | 4 | 2006 | 598 | 0.380 |
Why?
|
Tetradecanoylphorbol Acetate | 9 | 2003 | 825 | 0.380 |
Why?
|
Extracellular Fluid | 2 | 2010 | 165 | 0.370 |
Why?
|
Testicular Neoplasms | 4 | 2005 | 805 | 0.370 |
Why?
|
Spermine | 6 | 2004 | 70 | 0.370 |
Why?
|
Astrocytes | 6 | 2007 | 1351 | 0.360 |
Why?
|
Molecular Sequence Data | 36 | 2014 | 17605 | 0.350 |
Why?
|
Receptors, G-Protein-Coupled | 3 | 2015 | 1245 | 0.350 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 17 | 2008 | 4566 | 0.350 |
Why?
|
Receptors, Retinoic Acid | 2 | 2001 | 229 | 0.350 |
Why?
|
Type C Phospholipases | 7 | 2010 | 287 | 0.350 |
Why?
|
Naphthalenes | 2 | 2015 | 198 | 0.350 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 5 | 2003 | 635 | 0.340 |
Why?
|
Transcriptional Activation | 3 | 2005 | 1749 | 0.340 |
Why?
|
Cell Membrane | 22 | 2013 | 3640 | 0.340 |
Why?
|
Calcitriol | 9 | 2011 | 301 | 0.340 |
Why?
|
Adenoma | 17 | 2003 | 2155 | 0.330 |
Why?
|
Tumor Cells, Cultured | 17 | 2004 | 6105 | 0.330 |
Why?
|
Amino Acid Sequence | 30 | 2014 | 13410 | 0.330 |
Why?
|
Immunohistochemistry | 30 | 2003 | 11059 | 0.320 |
Why?
|
Phosphorylation | 15 | 2010 | 8300 | 0.320 |
Why?
|
Calcium, Dietary | 7 | 2013 | 527 | 0.320 |
Why?
|
Cells, Cultured | 43 | 2012 | 18979 | 0.320 |
Why?
|
Second Messenger Systems | 7 | 1998 | 203 | 0.320 |
Why?
|
Proteins | 8 | 2003 | 6002 | 0.320 |
Why?
|
Ergocalciferols | 3 | 2009 | 105 | 0.310 |
Why?
|
Kinetics | 41 | 2010 | 6285 | 0.310 |
Why?
|
Biomimetic Materials | 1 | 2010 | 170 | 0.310 |
Why?
|
Humans | 254 | 2015 | 766432 | 0.300 |
Why?
|
Tretinoin | 2 | 2001 | 524 | 0.300 |
Why?
|
Mutation | 37 | 2014 | 30220 | 0.300 |
Why?
|
Polymerase Chain Reaction | 22 | 2007 | 6061 | 0.300 |
Why?
|
Base Sequence | 26 | 2012 | 12412 | 0.290 |
Why?
|
Gene Expression | 14 | 2005 | 7583 | 0.290 |
Why?
|
Leydig Cells | 3 | 2005 | 55 | 0.290 |
Why?
|
Potassium | 9 | 2001 | 1314 | 0.290 |
Why?
|
Concanavalin A | 3 | 1992 | 189 | 0.280 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 6 | 2005 | 474 | 0.280 |
Why?
|
Minerals | 2 | 2006 | 278 | 0.280 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 3 | 2004 | 439 | 0.270 |
Why?
|
Fibroblast Growth Factors | 1 | 2012 | 871 | 0.270 |
Why?
|
DNA, Complementary | 14 | 2007 | 1988 | 0.270 |
Why?
|
Monocytes | 4 | 2000 | 2599 | 0.270 |
Why?
|
Gadolinium | 7 | 2000 | 963 | 0.260 |
Why?
|
Phenylalanine | 5 | 2014 | 366 | 0.260 |
Why?
|
Ion Channels | 7 | 2002 | 1043 | 0.260 |
Why?
|
Contractile Proteins | 2 | 2012 | 240 | 0.260 |
Why?
|
Cations | 9 | 2013 | 239 | 0.260 |
Why?
|
Bone Diseases, Metabolic | 1 | 2010 | 407 | 0.260 |
Why?
|
Secretory Vesicles | 1 | 2006 | 127 | 0.260 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2001 | 857 | 0.260 |
Why?
|
Duodenum | 1 | 2009 | 496 | 0.260 |
Why?
|
Transfection | 20 | 2008 | 5750 | 0.250 |
Why?
|
Dopamine | 21 | 1992 | 1581 | 0.250 |
Why?
|
Dose-Response Relationship, Drug | 26 | 2014 | 10740 | 0.250 |
Why?
|
Mice | 52 | 2015 | 81863 | 0.250 |
Why?
|
Osteoclasts | 4 | 2013 | 713 | 0.250 |
Why?
|
Patch-Clamp Techniques | 11 | 2007 | 924 | 0.250 |
Why?
|
Enzyme Activation | 17 | 2008 | 3585 | 0.250 |
Why?
|
Hydrogen-Ion Concentration | 7 | 2004 | 2477 | 0.250 |
Why?
|
Taste | 1 | 2006 | 190 | 0.250 |
Why?
|
Gene Expression Regulation | 15 | 2013 | 11919 | 0.240 |
Why?
|
Mice, Knockout | 16 | 2015 | 14466 | 0.240 |
Why?
|
DNA Primers | 11 | 2007 | 2824 | 0.240 |
Why?
|
Benzoates | 3 | 2013 | 213 | 0.230 |
Why?
|
Membrane Potentials | 11 | 2001 | 1085 | 0.230 |
Why?
|
Receptors, Adrenergic | 9 | 1982 | 155 | 0.230 |
Why?
|
Retinoids | 2 | 2001 | 99 | 0.230 |
Why?
|
Edetic Acid | 6 | 2001 | 276 | 0.230 |
Why?
|
Chemokine CCL2 | 1 | 2006 | 604 | 0.220 |
Why?
|
Isoproterenol | 22 | 1990 | 398 | 0.220 |
Why?
|
Glucocorticoids | 3 | 2010 | 2158 | 0.220 |
Why?
|
Parathyroid Diseases | 4 | 2003 | 46 | 0.220 |
Why?
|
Protein Structure, Secondary | 9 | 2014 | 1211 | 0.220 |
Why?
|
Genes, Dominant | 6 | 2002 | 855 | 0.220 |
Why?
|
Osteoporosis | 2 | 2010 | 1581 | 0.220 |
Why?
|
Hyperparathyroidism, Primary | 3 | 2012 | 164 | 0.220 |
Why?
|
Protein Conformation | 11 | 2009 | 3946 | 0.220 |
Why?
|
Oligodendroglia | 4 | 2008 | 539 | 0.220 |
Why?
|
Caveolin 1 | 4 | 2012 | 255 | 0.210 |
Why?
|
Fibrillar Collagens | 1 | 2003 | 42 | 0.210 |
Why?
|
Hysteria | 1 | 2003 | 20 | 0.210 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 6 | 2004 | 694 | 0.210 |
Why?
|
MAP Kinase Signaling System | 5 | 2014 | 1490 | 0.210 |
Why?
|
Endocrine System | 1 | 2004 | 112 | 0.210 |
Why?
|
Egtazic Acid | 8 | 2001 | 165 | 0.200 |
Why?
|
Calpain | 1 | 2003 | 146 | 0.200 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2004 | 304 | 0.200 |
Why?
|
Psychoanalytic Theory | 1 | 2003 | 128 | 0.200 |
Why?
|
MAP Kinase Kinase 1 | 5 | 2006 | 330 | 0.200 |
Why?
|
Microfilament Proteins | 2 | 2012 | 1129 | 0.190 |
Why?
|
TRPV Cation Channels | 8 | 2007 | 243 | 0.190 |
Why?
|
Psychoanalysis | 1 | 2003 | 84 | 0.190 |
Why?
|
Oocytes | 12 | 2006 | 1168 | 0.190 |
Why?
|
Structure-Activity Relationship | 9 | 2014 | 3053 | 0.190 |
Why?
|
Cytoskeleton | 1 | 2006 | 1179 | 0.190 |
Why?
|
Tissue Distribution | 8 | 2008 | 2275 | 0.190 |
Why?
|
Bone Marrow Cells | 3 | 2012 | 2413 | 0.190 |
Why?
|
Hip Fractures | 1 | 2010 | 996 | 0.190 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2009 | 2839 | 0.180 |
Why?
|
Xenopus laevis | 12 | 2011 | 965 | 0.180 |
Why?
|
Chelating Agents | 4 | 2001 | 380 | 0.180 |
Why?
|
Cytoskeletal Proteins | 1 | 2006 | 1324 | 0.180 |
Why?
|
Infant, Newborn, Diseases | 4 | 2008 | 587 | 0.180 |
Why?
|
Thyroid Gland | 3 | 2007 | 1170 | 0.180 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 5 | 2014 | 615 | 0.180 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2006 | 1142 | 0.180 |
Why?
|
Phospholipases A | 2 | 2001 | 204 | 0.180 |
Why?
|
Binding Sites | 15 | 2014 | 6010 | 0.180 |
Why?
|
Gastrointestinal Tract | 1 | 2006 | 834 | 0.180 |
Why?
|
Osmolar Concentration | 8 | 2002 | 655 | 0.170 |
Why?
|
Mutagenesis, Site-Directed | 10 | 2009 | 1677 | 0.170 |
Why?
|
Rats, Inbred F344 | 6 | 2005 | 820 | 0.170 |
Why?
|
Ion Pumps | 1 | 1999 | 15 | 0.170 |
Why?
|
TRPM Cation Channels | 4 | 2011 | 139 | 0.170 |
Why?
|
Ions | 4 | 2009 | 254 | 0.170 |
Why?
|
Protein Structure, Tertiary | 12 | 2014 | 3757 | 0.170 |
Why?
|
RNA-Directed DNA Polymerase | 5 | 1998 | 222 | 0.170 |
Why?
|
Polyendocrinopathies, Autoimmune | 3 | 2010 | 56 | 0.170 |
Why?
|
Metabolism, Inborn Errors | 3 | 1999 | 291 | 0.170 |
Why?
|
Peroxisomes | 1 | 2000 | 63 | 0.170 |
Why?
|
Cell Proliferation | 7 | 2015 | 10438 | 0.170 |
Why?
|
Lithium | 5 | 1999 | 599 | 0.160 |
Why?
|
Oxazoles | 1 | 2001 | 198 | 0.160 |
Why?
|
Transforming Growth Factor beta | 3 | 2007 | 1997 | 0.160 |
Why?
|
Antibodies, Antinuclear | 2 | 2011 | 340 | 0.160 |
Why?
|
Sodium Fluoride | 3 | 1989 | 60 | 0.160 |
Why?
|
Glycosylation | 9 | 2014 | 1100 | 0.160 |
Why?
|
Bartter Syndrome | 2 | 2009 | 23 | 0.160 |
Why?
|
Neurons | 8 | 2007 | 9515 | 0.160 |
Why?
|
Intracellular Fluid | 2 | 2001 | 201 | 0.160 |
Why?
|
Microscopy, Confocal | 3 | 2008 | 1967 | 0.160 |
Why?
|
Bone Remodeling | 3 | 2011 | 577 | 0.160 |
Why?
|
Parathyroidectomy | 4 | 2012 | 244 | 0.160 |
Why?
|
Osteosarcoma | 2 | 2002 | 908 | 0.160 |
Why?
|
Receptors, Dopamine | 4 | 1989 | 291 | 0.160 |
Why?
|
Subfornical Organ | 2 | 2004 | 10 | 0.160 |
Why?
|
Drug Delivery Systems | 1 | 2010 | 2210 | 0.160 |
Why?
|
Lactation | 3 | 2013 | 392 | 0.150 |
Why?
|
Mucolipidoses | 4 | 2011 | 82 | 0.150 |
Why?
|
Natriuresis | 1 | 1998 | 106 | 0.150 |
Why?
|
Mutation, Missense | 6 | 2015 | 2590 | 0.150 |
Why?
|
Colon | 2 | 2015 | 1798 | 0.150 |
Why?
|
Receptors, Parathyroid Hormone | 2 | 1996 | 332 | 0.150 |
Why?
|
Rats, Sprague-Dawley | 16 | 2007 | 8107 | 0.150 |
Why?
|
Calmodulin | 4 | 2010 | 240 | 0.150 |
Why?
|
Consciousness Disorders | 1 | 2003 | 445 | 0.150 |
Why?
|
Up-Regulation | 8 | 2015 | 4141 | 0.150 |
Why?
|
Membrane Proteins | 8 | 2004 | 7866 | 0.150 |
Why?
|
Apoptosis | 8 | 2015 | 9507 | 0.150 |
Why?
|
Immunoprecipitation | 3 | 2010 | 873 | 0.150 |
Why?
|
Ouabain | 4 | 1987 | 246 | 0.140 |
Why?
|
Mammary Glands, Animal | 2 | 2013 | 273 | 0.140 |
Why?
|
Threonine | 1 | 1998 | 272 | 0.140 |
Why?
|
Fibrocystic Breast Disease | 1 | 1998 | 103 | 0.140 |
Why?
|
Chickens | 4 | 2000 | 842 | 0.140 |
Why?
|
Receptors, Calcitonin | 2 | 1996 | 33 | 0.140 |
Why?
|
Glycerophospholipids | 1 | 1997 | 39 | 0.140 |
Why?
|
Enzyme Inhibitors | 6 | 2004 | 3721 | 0.140 |
Why?
|
Thiazolidinediones | 1 | 2000 | 460 | 0.140 |
Why?
|
Fura-2 | 7 | 2001 | 107 | 0.140 |
Why?
|
Transcription, Genetic | 10 | 2015 | 7607 | 0.140 |
Why?
|
Phospholipase D | 1 | 1997 | 71 | 0.140 |
Why?
|
Virulence Factors, Bordetella | 5 | 2001 | 154 | 0.140 |
Why?
|
Phosphates | 10 | 2009 | 763 | 0.140 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2015 | 8619 | 0.130 |
Why?
|
Embryonic and Fetal Development | 2 | 1996 | 420 | 0.130 |
Why?
|
Rabbits | 6 | 2008 | 4752 | 0.130 |
Why?
|
Calcium Channel Blockers | 5 | 2000 | 687 | 0.130 |
Why?
|
Recombinant Proteins | 11 | 2012 | 6507 | 0.130 |
Why?
|
Models, Molecular | 7 | 2012 | 5385 | 0.130 |
Why?
|
Protein Biosynthesis | 2 | 2006 | 2094 | 0.120 |
Why?
|
Point Mutation | 6 | 2000 | 1591 | 0.120 |
Why?
|
Brain Chemistry | 2 | 1997 | 951 | 0.120 |
Why?
|
Sodium | 8 | 2002 | 1593 | 0.120 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2005 | 2880 | 0.120 |
Why?
|
Receptors, Metabotropic Glutamate | 3 | 2013 | 187 | 0.120 |
Why?
|
Citrates | 4 | 1994 | 132 | 0.120 |
Why?
|
Sequence Alignment | 7 | 2014 | 2176 | 0.120 |
Why?
|
Uremia | 1 | 1996 | 202 | 0.120 |
Why?
|
Lens, Crystalline | 1 | 1997 | 387 | 0.120 |
Why?
|
Infant, Newborn | 19 | 2012 | 26388 | 0.120 |
Why?
|
Creatinine | 8 | 2009 | 1916 | 0.120 |
Why?
|
Neoplasms, Experimental | 1 | 2000 | 1227 | 0.120 |
Why?
|
Health | 1 | 1998 | 397 | 0.120 |
Why?
|
Muscle, Smooth | 2 | 1999 | 931 | 0.120 |
Why?
|
Male | 82 | 2015 | 363975 | 0.120 |
Why?
|
Pneumonia, Bacterial | 1 | 1997 | 319 | 0.120 |
Why?
|
Pindolol | 6 | 1977 | 34 | 0.120 |
Why?
|
Pertussis Toxin | 4 | 2001 | 176 | 0.110 |
Why?
|
Pedigree | 18 | 2003 | 4537 | 0.110 |
Why?
|
Epithelial Cells | 7 | 2004 | 3689 | 0.110 |
Why?
|
Reference Values | 10 | 2002 | 4913 | 0.110 |
Why?
|
Sequence Homology, Amino Acid | 9 | 2010 | 2746 | 0.110 |
Why?
|
Bone Resorption | 6 | 2013 | 721 | 0.110 |
Why?
|
Transcription Factors | 4 | 2012 | 12147 | 0.110 |
Why?
|
Receptors, Chemokine | 3 | 2006 | 652 | 0.110 |
Why?
|
Erythrocytes | 5 | 2013 | 2412 | 0.110 |
Why?
|
Models, Biological | 7 | 2009 | 9458 | 0.110 |
Why?
|
Cell Membrane Permeability | 5 | 2013 | 568 | 0.110 |
Why?
|
25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2010 | 57 | 0.110 |
Why?
|
Guanosine Triphosphate | 4 | 1990 | 314 | 0.110 |
Why?
|
Protein Synthesis Inhibitors | 3 | 2002 | 187 | 0.110 |
Why?
|
Osteocalcin | 3 | 2009 | 271 | 0.110 |
Why?
|
Bromodeoxyuridine | 2 | 2004 | 310 | 0.110 |
Why?
|
Pituitary Gland | 1 | 1996 | 635 | 0.110 |
Why?
|
In Situ Hybridization | 9 | 2002 | 1887 | 0.100 |
Why?
|
Diltiazem | 2 | 1990 | 132 | 0.100 |
Why?
|
Caveolae | 2 | 2003 | 54 | 0.100 |
Why?
|
Stromal Cells | 1 | 1998 | 1335 | 0.100 |
Why?
|
Protein Kinases | 4 | 1984 | 1608 | 0.100 |
Why?
|
Intestine, Small | 2 | 2001 | 1217 | 0.100 |
Why?
|
Isoenzymes | 5 | 2012 | 1688 | 0.100 |
Why?
|
Disease | 1 | 1998 | 675 | 0.100 |
Why?
|
Hyperplasia | 9 | 1997 | 1150 | 0.100 |
Why?
|
Dimerization | 5 | 2002 | 882 | 0.100 |
Why?
|
Prostatic Neoplasms | 4 | 2004 | 11094 | 0.100 |
Why?
|
Synaptic Transmission | 2 | 2004 | 1175 | 0.100 |
Why?
|
Guanylyl Imidodiphosphate | 3 | 1990 | 37 | 0.100 |
Why?
|
Calcium Gluconate | 6 | 2012 | 22 | 0.100 |
Why?
|
Ligands | 6 | 2015 | 3276 | 0.100 |
Why?
|
Phosphatidylinositols | 1 | 1992 | 280 | 0.100 |
Why?
|
Female | 78 | 2015 | 396354 | 0.100 |
Why?
|
Antibody Specificity | 3 | 2007 | 1062 | 0.090 |
Why?
|
Meningioma | 1 | 2000 | 1221 | 0.090 |
Why?
|
Cell Line, Tumor | 8 | 2015 | 17082 | 0.090 |
Why?
|
Glioblastoma | 4 | 2004 | 3458 | 0.090 |
Why?
|
Cell Differentiation | 6 | 2015 | 11648 | 0.090 |
Why?
|
Precipitin Tests | 3 | 2004 | 816 | 0.090 |
Why?
|
Polylysine | 1 | 1991 | 130 | 0.090 |
Why?
|
Protamines | 1 | 1991 | 112 | 0.090 |
Why?
|
Microglia | 2 | 2004 | 1370 | 0.090 |
Why?
|
Neoplasm Transplantation | 3 | 2004 | 2010 | 0.090 |
Why?
|
Meningeal Neoplasms | 1 | 2000 | 1255 | 0.090 |
Why?
|
Aniline Compounds | 4 | 2015 | 1079 | 0.090 |
Why?
|
Amino Acid Substitution | 5 | 2015 | 1742 | 0.090 |
Why?
|
3',5'-Cyclic-AMP Phosphodiesterases | 7 | 1989 | 50 | 0.090 |
Why?
|
Inositol 1,4,5-Trisphosphate | 4 | 1998 | 110 | 0.090 |
Why?
|
Stimulation, Chemical | 1 | 2010 | 305 | 0.090 |
Why?
|
Adenosine Diphosphate | 2 | 2002 | 421 | 0.090 |
Why?
|
Injections, Intraperitoneal | 2 | 2009 | 410 | 0.090 |
Why?
|
Intestinal Absorption | 2 | 2009 | 400 | 0.090 |
Why?
|
Kidney Cortex | 3 | 2000 | 167 | 0.090 |
Why?
|
Kidney Medulla | 4 | 1998 | 169 | 0.090 |
Why?
|
Phorbol Esters | 1 | 1990 | 109 | 0.090 |
Why?
|
Citric Acid | 6 | 2000 | 124 | 0.090 |
Why?
|
Lysosomes | 3 | 2006 | 937 | 0.090 |
Why?
|
Stem Cells | 3 | 2015 | 3538 | 0.090 |
Why?
|
Thiazepines | 1 | 1990 | 30 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 1998 | 1097 | 0.090 |
Why?
|
Lithium Carbonate | 2 | 2007 | 179 | 0.090 |
Why?
|
Gene Deletion | 2 | 2013 | 2668 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 2 | 2015 | 2799 | 0.090 |
Why?
|
Prostaglandins | 4 | 1985 | 398 | 0.090 |
Why?
|
Tryptophan | 2 | 2004 | 484 | 0.090 |
Why?
|
Animals, Newborn | 7 | 2013 | 2675 | 0.090 |
Why?
|
Antibodies, Blocking | 1 | 2010 | 250 | 0.090 |
Why?
|
Receptors, Adrenergic, beta | 5 | 1981 | 243 | 0.090 |
Why?
|
Adrenocorticotropic Hormone | 4 | 1999 | 618 | 0.090 |
Why?
|
Molecular Weight | 6 | 1998 | 2168 | 0.090 |
Why?
|
Hypercalciuria | 1 | 2009 | 31 | 0.080 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2015 | 756 | 0.080 |
Why?
|
Brain Neoplasms | 5 | 2004 | 9101 | 0.080 |
Why?
|
HEK293 Cells | 6 | 2014 | 4270 | 0.080 |
Why?
|
Neoplasms | 3 | 2012 | 22343 | 0.080 |
Why?
|
Anti-Bacterial Agents | 4 | 1997 | 7475 | 0.080 |
Why?
|
Protein Multimerization | 1 | 2014 | 960 | 0.080 |
Why?
|
Aminoquinolines | 6 | 1987 | 105 | 0.080 |
Why?
|
Osteogenesis | 3 | 2011 | 1282 | 0.080 |
Why?
|
Drug Resistance | 2 | 2010 | 1591 | 0.080 |
Why?
|
Calcifediol | 2 | 2009 | 156 | 0.080 |
Why?
|
Kidney Tubules, Proximal | 1 | 1991 | 386 | 0.080 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 2003 | 1729 | 0.080 |
Why?
|
Sjogren's Syndrome | 1 | 2011 | 240 | 0.080 |
Why?
|
Phospholipases A2 | 2 | 2001 | 197 | 0.080 |
Why?
|
Drug Implants | 1 | 2009 | 230 | 0.080 |
Why?
|
Nitric Oxide Synthase | 2 | 2005 | 911 | 0.080 |
Why?
|
Adrenergic beta-Agonists | 4 | 1980 | 345 | 0.080 |
Why?
|
Glycerides | 1 | 1988 | 67 | 0.080 |
Why?
|
Breast | 1 | 1998 | 1971 | 0.080 |
Why?
|
Tooth Socket | 1 | 2010 | 126 | 0.080 |
Why?
|
Ion Channel Gating | 3 | 2000 | 428 | 0.080 |
Why?
|
Apolipoproteins A | 1 | 1989 | 95 | 0.080 |
Why?
|
Intestinal Mucosa | 2 | 2011 | 3048 | 0.080 |
Why?
|
Cell Count | 2 | 2006 | 1826 | 0.080 |
Why?
|
Lipase | 1 | 2011 | 320 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2001 | 4400 | 0.080 |
Why?
|
Models, Chemical | 2 | 2009 | 607 | 0.080 |
Why?
|
Conserved Sequence | 4 | 2002 | 1159 | 0.080 |
Why?
|
Trophoblasts | 2 | 2002 | 223 | 0.080 |
Why?
|
Exocytosis | 3 | 2006 | 323 | 0.080 |
Why?
|
Tooth | 1 | 2010 | 210 | 0.080 |
Why?
|
Diglycerides | 1 | 1988 | 175 | 0.080 |
Why?
|
Cross Infection | 1 | 1997 | 1427 | 0.080 |
Why?
|
Tea | 1 | 2010 | 289 | 0.080 |
Why?
|
Disulfides | 3 | 2000 | 462 | 0.070 |
Why?
|
Norepinephrine | 8 | 1980 | 898 | 0.070 |
Why?
|
Water | 3 | 2000 | 1417 | 0.070 |
Why?
|
Alkaline Phosphatase | 4 | 1998 | 855 | 0.070 |
Why?
|
Benzofurans | 2 | 1989 | 139 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2002 | 562 | 0.070 |
Why?
|
Receptors, CCR2 | 2 | 2006 | 215 | 0.070 |
Why?
|
Cartilage | 1 | 2011 | 811 | 0.070 |
Why?
|
Amino Acid Transport Systems, Basic | 3 | 2001 | 35 | 0.070 |
Why?
|
Diabetes Insipidus, Nephrogenic | 1 | 2007 | 20 | 0.070 |
Why?
|
Synapses | 1 | 1997 | 1759 | 0.070 |
Why?
|
Ionomycin | 4 | 2002 | 109 | 0.070 |
Why?
|
Caffeine | 2 | 2010 | 702 | 0.070 |
Why?
|
Monocyte Chemoattractant Proteins | 1 | 2007 | 48 | 0.070 |
Why?
|
Tyrosine | 2 | 2004 | 1425 | 0.070 |
Why?
|
Gastric Mucosa | 3 | 2001 | 602 | 0.070 |
Why?
|
Thermodynamics | 4 | 2014 | 578 | 0.070 |
Why?
|
Chondrocytes | 2 | 2011 | 799 | 0.070 |
Why?
|
Kidney Tubules, Collecting | 2 | 1998 | 163 | 0.070 |
Why?
|
Calcimycin | 3 | 1983 | 214 | 0.070 |
Why?
|
Binding Sites, Antibody | 1 | 1987 | 340 | 0.070 |
Why?
|
Calcium-Transporting ATPases | 2 | 2001 | 122 | 0.070 |
Why?
|
Cyclin D1 | 2 | 2015 | 454 | 0.070 |
Why?
|
Radioimmunoassay | 5 | 2007 | 861 | 0.070 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1997 | 1056 | 0.070 |
Why?
|
Vitamin D | 4 | 2013 | 3270 | 0.060 |
Why?
|
Respiration, Artificial | 1 | 1997 | 2727 | 0.060 |
Why?
|
Protein Interaction Mapping | 1 | 2010 | 621 | 0.060 |
Why?
|
Vasopressins | 2 | 1998 | 358 | 0.060 |
Why?
|
Phenotype | 7 | 2015 | 16721 | 0.060 |
Why?
|
Kidney Failure, Chronic | 2 | 2013 | 2505 | 0.060 |
Why?
|
Mobility Limitation | 1 | 2010 | 409 | 0.060 |
Why?
|
Hypothyroidism | 1 | 2011 | 665 | 0.060 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 2000 | 322 | 0.060 |
Why?
|
Immunoradiometric Assay | 2 | 1998 | 20 | 0.060 |
Why?
|
Antigens, Surface | 2 | 1987 | 1617 | 0.060 |
Why?
|
Transient Receptor Potential Channels | 4 | 2011 | 130 | 0.060 |
Why?
|
Physical Fitness | 1 | 2010 | 743 | 0.060 |
Why?
|
1-Methyl-3-isobutylxanthine | 4 | 1989 | 100 | 0.060 |
Why?
|
Hippocampus | 5 | 2004 | 3776 | 0.060 |
Why?
|
Aging | 5 | 2001 | 8725 | 0.060 |
Why?
|
Chemokines, CXC | 1 | 2007 | 420 | 0.060 |
Why?
|
Xenopus | 6 | 2006 | 709 | 0.060 |
Why?
|
Epinephrine | 6 | 1979 | 782 | 0.060 |
Why?
|
Potassium Chloride | 2 | 1984 | 228 | 0.060 |
Why?
|
Phospholipids | 1 | 1989 | 778 | 0.060 |
Why?
|
Peptides | 3 | 2010 | 4344 | 0.060 |
Why?
|
Polymorphism, Genetic | 3 | 2008 | 4249 | 0.060 |
Why?
|
Phorbols | 1 | 1984 | 44 | 0.060 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2010 | 698 | 0.060 |
Why?
|
Histamine | 3 | 1982 | 496 | 0.060 |
Why?
|
Histocytochemistry | 3 | 1997 | 697 | 0.060 |
Why?
|
Tyrphostins | 1 | 2004 | 62 | 0.060 |
Why?
|
Calcium Chloride | 3 | 1998 | 78 | 0.060 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 2 | 2003 | 166 | 0.060 |
Why?
|
Dinoprost | 4 | 1990 | 139 | 0.060 |
Why?
|
Cytoplasm | 3 | 2004 | 1505 | 0.060 |
Why?
|
Phosphoric Diester Hydrolases | 2 | 1987 | 205 | 0.060 |
Why?
|
Bone Density | 6 | 2013 | 3491 | 0.060 |
Why?
|
Immunoglobulin E | 1 | 2010 | 1495 | 0.060 |
Why?
|
Lipoproteins, HDL | 1 | 1989 | 676 | 0.060 |
Why?
|
Diphosphonates | 1 | 2009 | 625 | 0.060 |
Why?
|
Epithelium | 4 | 2003 | 1606 | 0.060 |
Why?
|
Activin Receptors | 1 | 2004 | 40 | 0.060 |
Why?
|
Chemokine CCL5 | 1 | 2005 | 214 | 0.060 |
Why?
|
Inhibin-beta Subunits | 1 | 2004 | 27 | 0.060 |
Why?
|
Biological Transport | 5 | 2013 | 2083 | 0.060 |
Why?
|
Cyclin D | 1 | 2004 | 70 | 0.060 |
Why?
|
Potassium Channels, Calcium-Activated | 1 | 2004 | 43 | 0.060 |
Why?
|
Time Factors | 17 | 2005 | 40116 | 0.060 |
Why?
|
RNA, Complementary | 2 | 2001 | 46 | 0.060 |
Why?
|
Early Growth Response Protein 1 | 1 | 2004 | 133 | 0.060 |
Why?
|
DNA | 6 | 2006 | 7207 | 0.060 |
Why?
|
Neoplasm Proteins | 3 | 2004 | 3601 | 0.060 |
Why?
|
Metabolic Clearance Rate | 2 | 1998 | 361 | 0.060 |
Why?
|
Phosphatidic Acids | 2 | 1997 | 50 | 0.060 |
Why?
|
Propranolol | 9 | 1979 | 493 | 0.060 |
Why?
|
Autolysis | 1 | 2003 | 13 | 0.050 |
Why?
|
Rubidium | 1 | 1983 | 120 | 0.050 |
Why?
|
Addison Disease | 1 | 2004 | 48 | 0.050 |
Why?
|
Organ Specificity | 4 | 2005 | 1966 | 0.050 |
Why?
|
Down-Regulation | 3 | 2015 | 2930 | 0.050 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 3 | 2014 | 502 | 0.050 |
Why?
|
Diterpenes | 1 | 1984 | 169 | 0.050 |
Why?
|
Computer Simulation | 1 | 1997 | 6259 | 0.050 |
Why?
|
Smad Proteins | 1 | 2004 | 157 | 0.050 |
Why?
|
Macrophages | 1 | 1998 | 5782 | 0.050 |
Why?
|
Starvation | 1 | 2004 | 141 | 0.050 |
Why?
|
Prostaglandins F | 6 | 1985 | 79 | 0.050 |
Why?
|
Somnambulism | 1 | 2003 | 13 | 0.050 |
Why?
|
Adult | 43 | 2010 | 223253 | 0.050 |
Why?
|
India | 1 | 2010 | 2335 | 0.050 |
Why?
|
Catecholamines | 3 | 1982 | 388 | 0.050 |
Why?
|
Collagen | 1 | 1991 | 2634 | 0.050 |
Why?
|
Corpus Striatum | 1 | 1989 | 1218 | 0.050 |
Why?
|
Polycystic Kidney Diseases | 2 | 2001 | 133 | 0.050 |
Why?
|
Anisomycin | 1 | 2002 | 27 | 0.050 |
Why?
|
Receptors, Amino Acid | 1 | 2002 | 30 | 0.050 |
Why?
|
Peptide Fragments | 5 | 2004 | 5129 | 0.050 |
Why?
|
Relaxin | 1 | 2003 | 42 | 0.050 |
Why?
|
Milk | 3 | 2013 | 436 | 0.050 |
Why?
|
Kidney Calculi | 1 | 2007 | 458 | 0.050 |
Why?
|
Mice, Inbred C57BL | 7 | 2012 | 22337 | 0.050 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2003 | 147 | 0.050 |
Why?
|
Collagenases | 1 | 2003 | 221 | 0.050 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2002 | 92 | 0.050 |
Why?
|
Culture Media, Conditioned | 1 | 2004 | 520 | 0.050 |
Why?
|
Hypnosis | 1 | 2003 | 83 | 0.050 |
Why?
|
Paracrine Communication | 2 | 2001 | 277 | 0.050 |
Why?
|
Activins | 1 | 2004 | 211 | 0.050 |
Why?
|
Circular Dichroism | 3 | 2010 | 333 | 0.050 |
Why?
|
Graves Disease | 1 | 2004 | 239 | 0.050 |
Why?
|
Molecular Structure | 3 | 2002 | 1881 | 0.050 |
Why?
|
Neovascularization, Pathologic | 2 | 2004 | 2629 | 0.050 |
Why?
|
Middle Aged | 33 | 2012 | 223127 | 0.050 |
Why?
|
Chorionic Villi | 1 | 2002 | 53 | 0.050 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2004 | 343 | 0.050 |
Why?
|
Arachidonic Acid | 2 | 1997 | 430 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2000 | 21157 | 0.050 |
Why?
|
Urban Population | 1 | 2010 | 2038 | 0.050 |
Why?
|
Sodium Chloride | 4 | 2002 | 579 | 0.050 |
Why?
|
Cyclins | 1 | 2004 | 604 | 0.050 |
Why?
|
Elastin | 1 | 2003 | 299 | 0.050 |
Why?
|
France | 1 | 2003 | 495 | 0.050 |
Why?
|
Consensus Sequence | 2 | 2010 | 363 | 0.050 |
Why?
|
Antibodies | 2 | 2002 | 2421 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2004 | 582 | 0.050 |
Why?
|
Renin-Angiotensin System | 2 | 1999 | 735 | 0.050 |
Why?
|
Adenoviridae Infections | 1 | 2001 | 97 | 0.050 |
Why?
|
Intracellular Space | 2 | 2014 | 198 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3803 | 0.050 |
Why?
|
Intracellular Membranes | 3 | 2004 | 386 | 0.050 |
Why?
|
Immediate-Early Proteins | 1 | 2004 | 444 | 0.050 |
Why?
|
Cell Separation | 5 | 1997 | 1718 | 0.050 |
Why?
|
Molecular Dynamics Simulation | 2 | 2014 | 422 | 0.050 |
Why?
|
Bone Density Conservation Agents | 1 | 2008 | 791 | 0.050 |
Why?
|
Ameloblasts | 1 | 2000 | 17 | 0.050 |
Why?
|
Adrenergic beta-Antagonists | 2 | 1977 | 1236 | 0.050 |
Why?
|
Amelogenesis | 1 | 2000 | 6 | 0.050 |
Why?
|
Fluorescent Antibody Technique, Indirect | 2 | 1998 | 425 | 0.050 |
Why?
|
Retinoid X Receptors | 1 | 2001 | 91 | 0.050 |
Why?
|
Principal Component Analysis | 2 | 2014 | 948 | 0.050 |
Why?
|
Carcinogens | 1 | 2003 | 452 | 0.050 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 1 | 2001 | 89 | 0.040 |
Why?
|
Receptors, Endothelin | 1 | 2000 | 56 | 0.040 |
Why?
|
Macrocyclic Compounds | 1 | 2001 | 68 | 0.040 |
Why?
|
Analysis of Variance | 4 | 2004 | 6212 | 0.040 |
Why?
|
Activities of Daily Living | 1 | 2010 | 2429 | 0.040 |
Why?
|
Hematopoietic Stem Cells | 2 | 2005 | 3407 | 0.040 |
Why?
|
Phospholipases | 1 | 2000 | 75 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 4 | 2000 | 1963 | 0.040 |
Why?
|
Catalase | 1 | 2000 | 215 | 0.040 |
Why?
|
Renal Dialysis | 1 | 2010 | 1790 | 0.040 |
Why?
|
Sequence Analysis, DNA | 7 | 2003 | 4779 | 0.040 |
Why?
|
History, 19th Century | 1 | 2003 | 713 | 0.040 |
Why?
|
Aged | 20 | 2010 | 171234 | 0.040 |
Why?
|
Sex | 1 | 2000 | 52 | 0.040 |
Why?
|
Prostaglandin D2 | 1 | 2000 | 109 | 0.040 |
Why?
|
Autocrine Communication | 1 | 2001 | 167 | 0.040 |
Why?
|
Pancuronium | 1 | 1979 | 44 | 0.040 |
Why?
|
Strontium | 2 | 1990 | 22 | 0.040 |
Why?
|
Barium | 2 | 1990 | 62 | 0.040 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2004 | 637 | 0.040 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2006 | 1494 | 0.040 |
Why?
|
DNA Fragmentation | 1 | 2000 | 238 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 1987 | 9243 | 0.040 |
Why?
|
src-Family Kinases | 1 | 2002 | 540 | 0.040 |
Why?
|
Rats, Wistar | 2 | 2006 | 1889 | 0.040 |
Why?
|
Stereoisomerism | 2 | 1999 | 612 | 0.040 |
Why?
|
HL-60 Cells | 1 | 2000 | 364 | 0.040 |
Why?
|
Skull | 1 | 2004 | 819 | 0.040 |
Why?
|
Nephrons | 1 | 2000 | 165 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2003 | 1749 | 0.040 |
Why?
|
Nucleotides, Cyclic | 1 | 1980 | 83 | 0.040 |
Why?
|
3T3 Cells | 1 | 2000 | 1082 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2010 | 2101 | 0.040 |
Why?
|
Prostaglandins E | 4 | 1985 | 166 | 0.040 |
Why?
|
Fishes | 1 | 2002 | 607 | 0.040 |
Why?
|
Iodoacetamide | 1 | 1998 | 33 | 0.040 |
Why?
|
Absorption | 2 | 1998 | 242 | 0.040 |
Why?
|
Vitamin D Deficiency | 3 | 2000 | 1348 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 1995 | 1697 | 0.040 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2004 | 844 | 0.040 |
Why?
|
Cilia | 1 | 2003 | 498 | 0.040 |
Why?
|
Receptors, Adrenergic, alpha | 1 | 1978 | 146 | 0.040 |
Why?
|
Allosteric Regulation | 3 | 2013 | 425 | 0.040 |
Why?
|
Genotype | 2 | 2012 | 13034 | 0.040 |
Why?
|
Trifluoperazine | 3 | 1983 | 40 | 0.040 |
Why?
|
Kidney Concentrating Ability | 1 | 1998 | 34 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 2009 | 4888 | 0.040 |
Why?
|
Biotinylation | 1 | 1998 | 184 | 0.040 |
Why?
|
Protein Precursors | 3 | 1997 | 1134 | 0.040 |
Why?
|
Caspase 3 | 1 | 2000 | 730 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2005 | 18322 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2001 | 13639 | 0.040 |
Why?
|
Receptors, Vasopressin | 1 | 1998 | 106 | 0.040 |
Why?
|
Protein Binding | 8 | 2010 | 9315 | 0.040 |
Why?
|
Electrophysiology | 2 | 1999 | 1263 | 0.040 |
Why?
|
Anions | 1 | 1978 | 136 | 0.040 |
Why?
|
Caco-2 Cells | 2 | 2015 | 367 | 0.040 |
Why?
|
Cholecalciferol | 3 | 2001 | 550 | 0.040 |
Why?
|
Chemical Phenomena | 2 | 1991 | 485 | 0.040 |
Why?
|
Quinazolines | 1 | 2004 | 1367 | 0.040 |
Why?
|
Syndrome | 4 | 2003 | 3271 | 0.040 |
Why?
|
Feeding Behavior | 1 | 2010 | 3208 | 0.040 |
Why?
|
Hypophosphatemia, Familial | 2 | 1992 | 32 | 0.040 |
Why?
|
Receptor, Parathyroid Hormone, Type 1 | 2 | 1996 | 305 | 0.040 |
Why?
|
Staurosporine | 1 | 1998 | 241 | 0.040 |
Why?
|
Flavonoids | 1 | 2000 | 447 | 0.040 |
Why?
|
Immune Sera | 1 | 1997 | 605 | 0.040 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2000 | 661 | 0.040 |
Why?
|
Sheep | 2 | 2000 | 1448 | 0.040 |
Why?
|
Cholera Toxin | 2 | 1979 | 562 | 0.030 |
Why?
|
Caspases | 1 | 2000 | 881 | 0.030 |
Why?
|
Pregnancy | 10 | 2004 | 30235 | 0.030 |
Why?
|
Procollagen | 1 | 1997 | 189 | 0.030 |
Why?
|
Dietary Supplements | 1 | 2010 | 3428 | 0.030 |
Why?
|
Multigene Family | 1 | 2000 | 1081 | 0.030 |
Why?
|
TRPP Cation Channels | 3 | 2003 | 177 | 0.030 |
Why?
|
Punctures | 1 | 1998 | 370 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 3 | 2002 | 2470 | 0.030 |
Why?
|
Lactams | 1 | 1997 | 159 | 0.030 |
Why?
|
Immunoglobulin G | 2 | 2009 | 4559 | 0.030 |
Why?
|
DNA Mutational Analysis | 4 | 2001 | 4114 | 0.030 |
Why?
|
Ethers | 2 | 1989 | 72 | 0.030 |
Why?
|
DNA-Binding Proteins | 2 | 2004 | 9611 | 0.030 |
Why?
|
Pilot Projects | 1 | 2010 | 8720 | 0.030 |
Why?
|
Terpenes | 1 | 1996 | 102 | 0.030 |
Why?
|
Dinoprostone | 3 | 1990 | 597 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2004 | 1935 | 0.030 |
Why?
|
Bucladesine | 4 | 1986 | 118 | 0.030 |
Why?
|
History, 20th Century | 2 | 2003 | 2764 | 0.030 |
Why?
|
Sequence Homology | 1 | 1996 | 197 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2005 | 2141 | 0.030 |
Why?
|
Restriction Mapping | 1 | 1996 | 848 | 0.030 |
Why?
|
Urea | 1 | 1998 | 449 | 0.030 |
Why?
|
Chlorides | 2 | 1995 | 666 | 0.030 |
Why?
|
Genes, myc | 1 | 1997 | 391 | 0.030 |
Why?
|
NF-kappa B | 3 | 2012 | 2495 | 0.030 |
Why?
|
Chromosome Mapping | 4 | 2000 | 4618 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2001 | 1103 | 0.030 |
Why?
|
Genes | 2 | 1997 | 1824 | 0.030 |
Why?
|
Surface Properties | 1 | 1998 | 1153 | 0.030 |
Why?
|
Microscopy, Electron | 3 | 1991 | 2551 | 0.030 |
Why?
|
Cross-Linking Reagents | 1 | 1998 | 689 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2010 | 6217 | 0.030 |
Why?
|
Heterozygote | 5 | 2003 | 2795 | 0.030 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 1998 | 707 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2010 | 22245 | 0.030 |
Why?
|
Diffusion | 1 | 1997 | 808 | 0.030 |
Why?
|
Comorbidity | 1 | 2010 | 10579 | 0.030 |
Why?
|
Cells | 1 | 1996 | 162 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 1992 | 1528 | 0.030 |
Why?
|
Drug Design | 1 | 2000 | 1042 | 0.030 |
Why?
|
Sequence Analysis | 1 | 1995 | 240 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6962 | 0.030 |
Why?
|
Homozygote | 3 | 2011 | 1774 | 0.030 |
Why?
|
Chronic Disease | 1 | 2010 | 9352 | 0.030 |
Why?
|
Phenethylamines | 1 | 2015 | 95 | 0.030 |
Why?
|
HT29 Cells | 1 | 2015 | 187 | 0.030 |
Why?
|
1,2-Dipalmitoylphosphatidylcholine | 1 | 1994 | 40 | 0.030 |
Why?
|
Turkeys | 5 | 1976 | 44 | 0.030 |
Why?
|
Imidazoles | 1 | 2000 | 1168 | 0.030 |
Why?
|
Absorptiometry, Photon | 2 | 2012 | 1707 | 0.030 |
Why?
|
Cobalt | 1 | 1974 | 148 | 0.030 |
Why?
|
Iodine Radioisotopes | 3 | 2005 | 1030 | 0.030 |
Why?
|
Fluorescence | 2 | 1991 | 751 | 0.030 |
Why?
|
Propylamines | 1 | 2015 | 161 | 0.030 |
Why?
|
Trans-Activators | 1 | 2004 | 2854 | 0.030 |
Why?
|
Protein Engineering | 2 | 2009 | 554 | 0.030 |
Why?
|
Quisqualic Acid | 1 | 2013 | 35 | 0.030 |
Why?
|
Mathematics | 4 | 1983 | 696 | 0.030 |
Why?
|
Sequence Deletion | 1 | 1998 | 1494 | 0.030 |
Why?
|
Disease Progression | 2 | 2009 | 13632 | 0.030 |
Why?
|
Seroepidemiologic Studies | 2 | 2007 | 404 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2013 | 12807 | 0.030 |
Why?
|
Xanthenes | 1 | 2013 | 71 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2002 | 3608 | 0.030 |
Why?
|
Fluorescent Dyes | 4 | 1986 | 1927 | 0.030 |
Why?
|
Lactoglobulins | 1 | 2013 | 22 | 0.030 |
Why?
|
Guanine Nucleotides | 3 | 1987 | 55 | 0.030 |
Why?
|
Interleukin-1 | 1 | 1997 | 1251 | 0.030 |
Why?
|
Endosomes | 3 | 2004 | 521 | 0.030 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2013 | 142 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2010 | 14643 | 0.030 |
Why?
|
Haplotypes | 2 | 2004 | 2727 | 0.030 |
Why?
|
Flow Cytometry | 3 | 2010 | 5890 | 0.030 |
Why?
|
Osmosis | 1 | 2013 | 103 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2002 | 2426 | 0.030 |
Why?
|
Exercise | 1 | 2010 | 5943 | 0.030 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2015 | 414 | 0.030 |
Why?
|
Nerve Fibers | 1 | 1997 | 706 | 0.030 |
Why?
|
Cell Communication | 1 | 2000 | 1658 | 0.030 |
Why?
|
Benzazepines | 3 | 1989 | 307 | 0.030 |
Why?
|
Genetic Diseases, Inborn | 1 | 1998 | 606 | 0.030 |
Why?
|
Framycetin | 1 | 1992 | 7 | 0.030 |
Why?
|
Chromatography, Thin Layer | 1 | 1992 | 211 | 0.030 |
Why?
|
Paromomycin | 1 | 1992 | 14 | 0.030 |
Why?
|
Thiazoles | 1 | 2000 | 1528 | 0.030 |
Why?
|
Mice, Mutant Strains | 2 | 2011 | 1750 | 0.030 |
Why?
|
Metal Metabolism, Inborn Errors | 1 | 1992 | 14 | 0.030 |
Why?
|
Phentolamine | 5 | 1979 | 102 | 0.030 |
Why?
|
Rickets | 1 | 1992 | 66 | 0.030 |
Why?
|
Sodium-Potassium-Chloride Symporters | 1 | 2012 | 106 | 0.030 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2013 | 123 | 0.030 |
Why?
|
Tobramycin | 1 | 1992 | 65 | 0.030 |
Why?
|
Adrenal Glands | 2 | 1986 | 556 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 1998 | 2223 | 0.020 |
Why?
|
Carbamates | 1 | 2013 | 191 | 0.020 |
Why?
|
Gene Library | 3 | 2001 | 1065 | 0.020 |
Why?
|
DNA Transposable Elements | 1 | 1996 | 765 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2013 | 752 | 0.020 |
Why?
|
Acid Phosphatase | 1 | 2012 | 141 | 0.020 |
Why?
|
Brain | 5 | 2008 | 27156 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2014 | 487 | 0.020 |
Why?
|
Mammals | 1 | 1997 | 1134 | 0.020 |
Why?
|
Chemistry, Physical | 1 | 1991 | 152 | 0.020 |
Why?
|
Infusions, Intravenous | 3 | 1996 | 2227 | 0.020 |
Why?
|
Claudins | 1 | 2012 | 118 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2012 | 368 | 0.020 |
Why?
|
Steroid Hydroxylases | 1 | 2011 | 93 | 0.020 |
Why?
|
Hydrolysis | 1 | 1992 | 645 | 0.020 |
Why?
|
Gentamicins | 1 | 1992 | 244 | 0.020 |
Why?
|
Membrane Fusion Proteins | 1 | 2011 | 3 | 0.020 |
Why?
|
Intubation, Intratracheal | 1 | 1979 | 1359 | 0.020 |
Why?
|
Ferricyanides | 2 | 1981 | 31 | 0.020 |
Why?
|
Receptors, Dopamine D1 | 2 | 1989 | 276 | 0.020 |
Why?
|
Porosity | 1 | 2012 | 347 | 0.020 |
Why?
|
Zona Glomerulosa | 1 | 1991 | 87 | 0.020 |
Why?
|
Membrane Glycoproteins | 2 | 1999 | 3702 | 0.020 |
Why?
|
X-Ray Diffraction | 1 | 1991 | 413 | 0.020 |
Why?
|
Fluorides | 2 | 1990 | 134 | 0.020 |
Why?
|
Indomethacin | 3 | 1990 | 323 | 0.020 |
Why?
|
Cell Lineage | 2 | 2011 | 2573 | 0.020 |
Why?
|
Mice, Transgenic | 3 | 2013 | 9539 | 0.020 |
Why?
|
Methylglucosides | 1 | 1990 | 35 | 0.020 |
Why?
|
Zinc | 1 | 1974 | 675 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1999 | 2446 | 0.020 |
Why?
|
Nitroprusside | 2 | 1981 | 271 | 0.020 |
Why?
|
Algorithms | 2 | 2010 | 14071 | 0.020 |
Why?
|
Cell Survival | 1 | 2000 | 5741 | 0.020 |
Why?
|
Cadherins | 1 | 2015 | 901 | 0.020 |
Why?
|
Glycine | 1 | 2013 | 671 | 0.020 |
Why?
|
Macromolecular Substances | 2 | 1989 | 1431 | 0.020 |
Why?
|
Probenecid | 3 | 1978 | 72 | 0.020 |
Why?
|
Mutagenesis | 2 | 2007 | 1228 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2000 | 3607 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2007 | 9521 | 0.020 |
Why?
|
beta Catenin | 1 | 2015 | 1047 | 0.020 |
Why?
|
Escherichia coli | 2 | 2009 | 4211 | 0.020 |
Why?
|
Circadian Rhythm | 2 | 2002 | 2592 | 0.020 |
Why?
|
Exons | 3 | 2001 | 2392 | 0.020 |
Why?
|
Affinity Labels | 1 | 1989 | 107 | 0.020 |
Why?
|
Postpartum Period | 1 | 1997 | 1195 | 0.020 |
Why?
|
Homeodomain Proteins | 2 | 2012 | 2430 | 0.020 |
Why?
|
Anilino Naphthalenesulfonates | 1 | 2009 | 16 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 2 | 2005 | 1305 | 0.020 |
Why?
|
Azides | 1 | 1989 | 120 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 1989 | 283 | 0.020 |
Why?
|
Adenylate Cyclase Toxin | 1 | 1989 | 25 | 0.020 |
Why?
|
Pregnancy in Diabetics | 1 | 1991 | 198 | 0.020 |
Why?
|
Peptide Mapping | 1 | 1989 | 259 | 0.020 |
Why?
|
Adenosine Diphosphate Ribose | 1 | 1989 | 70 | 0.020 |
Why?
|
Burns | 1 | 2000 | 1902 | 0.020 |
Why?
|
Energy Transfer | 1 | 2009 | 108 | 0.020 |
Why?
|
Transplantation, Autologous | 5 | 1980 | 2127 | 0.020 |
Why?
|
Diacylglycerol Kinase | 1 | 1988 | 47 | 0.020 |
Why?
|
Cell Compartmentation | 2 | 2001 | 383 | 0.020 |
Why?
|
Secretin | 2 | 1979 | 57 | 0.020 |
Why?
|
Pyridines | 1 | 2000 | 2888 | 0.020 |
Why?
|
Autoradiography | 1 | 1989 | 725 | 0.020 |
Why?
|
Glucagon | 3 | 1980 | 534 | 0.020 |
Why?
|
Growth Plate | 1 | 2010 | 275 | 0.020 |
Why?
|
Peptide Library | 1 | 2010 | 351 | 0.020 |
Why?
|
Microscopy, Fluorescence | 2 | 2008 | 2629 | 0.020 |
Why?
|
Carbonated Beverages | 1 | 1989 | 209 | 0.020 |
Why?
|
Thapsigargin | 2 | 1999 | 102 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2000 | 2561 | 0.020 |
Why?
|
Fibroblasts | 2 | 2011 | 4164 | 0.020 |
Why?
|
Arachidonic Acids | 1 | 1988 | 295 | 0.020 |
Why?
|
Carcinoma | 2 | 1995 | 2323 | 0.020 |
Why?
|
Permeability | 1 | 1990 | 728 | 0.020 |
Why?
|
Angiotensin II | 2 | 1992 | 844 | 0.020 |
Why?
|
Kidney Tubules | 3 | 1998 | 453 | 0.020 |
Why?
|
Phosphotransferases | 1 | 1988 | 302 | 0.020 |
Why?
|
Hydroxides | 2 | 1978 | 46 | 0.020 |
Why?
|
Electrolytes | 1 | 1988 | 279 | 0.020 |
Why?
|
Ventricular Function, Right | 1 | 2012 | 629 | 0.020 |
Why?
|
Aluminum | 1 | 1988 | 150 | 0.020 |
Why?
|
RNA Splice Sites | 1 | 2008 | 212 | 0.020 |
Why?
|
Heart Failure | 1 | 2012 | 11816 | 0.020 |
Why?
|
Serine | 2 | 2002 | 829 | 0.020 |
Why?
|
Glycerol | 1 | 1988 | 274 | 0.020 |
Why?
|
Charybdotoxin | 1 | 2007 | 23 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2000 | 3107 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2007 | 3795 | 0.020 |
Why?
|
Apolipoprotein A-I | 1 | 1989 | 305 | 0.020 |
Why?
|
Chemokine CCL7 | 1 | 2007 | 30 | 0.020 |
Why?
|
Polymorphism, Single-Stranded Conformational | 2 | 1998 | 325 | 0.020 |
Why?
|
Computers | 2 | 1983 | 589 | 0.020 |
Why?
|
Hormones | 1 | 2011 | 866 | 0.020 |
Why?
|
Immunochemistry | 1 | 1987 | 116 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2008 | 432 | 0.020 |
Why?
|
Glycosylphosphatidylinositols | 1 | 2007 | 88 | 0.020 |
Why?
|
Genetic Linkage | 1 | 1992 | 2342 | 0.020 |
Why?
|
Child | 11 | 2010 | 80668 | 0.020 |
Why?
|
RNA | 2 | 2012 | 2715 | 0.020 |
Why?
|
COS Cells | 1 | 2008 | 1135 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2012 | 1516 | 0.020 |
Why?
|
Italy | 1 | 2008 | 855 | 0.020 |
Why?
|
Binding, Competitive | 3 | 1977 | 1141 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2012 | 912 | 0.020 |
Why?
|
Protein Transport | 2 | 2003 | 1940 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2007 | 423 | 0.020 |
Why?
|
Organ Size | 1 | 2011 | 2261 | 0.020 |
Why?
|
Neurotoxins | 1 | 2007 | 240 | 0.020 |
Why?
|
Estrogen Replacement Therapy | 1 | 1992 | 1205 | 0.020 |
Why?
|
Genes, bcl-1 | 1 | 2005 | 11 | 0.020 |
Why?
|
Chemokine CXCL10 | 1 | 2007 | 311 | 0.020 |
Why?
|
Microinjections | 2 | 2001 | 319 | 0.020 |
Why?
|
Rare Diseases | 1 | 2011 | 629 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2011 | 1029 | 0.020 |
Why?
|
Receptors, CCR1 | 1 | 2005 | 30 | 0.020 |
Why?
|
Femur | 1 | 2012 | 1318 | 0.020 |
Why?
|
Melitten | 1 | 1985 | 13 | 0.020 |
Why?
|
Receptors, CCR3 | 1 | 2005 | 62 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 1999 | 2971 | 0.020 |
Why?
|
6-Ketoprostaglandin F1 alpha | 1 | 1985 | 80 | 0.020 |
Why?
|
Thromboxane B2 | 1 | 1985 | 143 | 0.020 |
Why?
|
Receptors, CCR4 | 1 | 2005 | 77 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2002 | 5194 | 0.010 |
Why?
|
Cysteine | 2 | 2000 | 898 | 0.010 |
Why?
|
Risk Factors | 2 | 2010 | 74828 | 0.010 |
Why?
|
Adolescent | 9 | 2010 | 88898 | 0.010 |
Why?
|
Enzyme Induction | 1 | 2005 | 455 | 0.010 |
Why?
|
Biopsy | 1 | 1996 | 6778 | 0.010 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 1987 | 479 | 0.010 |
Why?
|
Mitogens | 1 | 2004 | 229 | 0.010 |
Why?
|
Fetal Blood | 1 | 1991 | 1366 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2005 | 610 | 0.010 |
Why?
|
Family Health | 1 | 2008 | 1253 | 0.010 |
Why?
|
Epoprostenol | 1 | 1985 | 246 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2012 | 15897 | 0.010 |
Why?
|
Amyloid beta-Peptides | 1 | 1997 | 3887 | 0.010 |
Why?
|
Embryo, Mammalian | 2 | 2000 | 1675 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2005 | 513 | 0.010 |
Why?
|
Interleukin-6 | 2 | 2004 | 3226 | 0.010 |
Why?
|
Epitopes | 1 | 2010 | 2526 | 0.010 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 319 | 0.010 |
Why?
|
Chemistry | 1 | 1983 | 327 | 0.010 |
Why?
|
Blood Physiological Phenomena | 1 | 2003 | 53 | 0.010 |
Why?
|
Membrane Fusion | 1 | 2004 | 265 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2015 | 2533 | 0.010 |
Why?
|
Long-Term Care | 1 | 2007 | 630 | 0.010 |
Why?
|
Lod Score | 2 | 1994 | 600 | 0.010 |
Why?
|
Ionophores | 1 | 2002 | 108 | 0.010 |
Why?
|
Transcription Factor RelA | 1 | 2004 | 252 | 0.010 |
Why?
|
Salmo salar | 1 | 2002 | 7 | 0.010 |
Why?
|
Chromogranin A | 1 | 1982 | 47 | 0.010 |
Why?
|
Olfactory Bulb | 1 | 2004 | 198 | 0.010 |
Why?
|
Dogfish | 1 | 2002 | 11 | 0.010 |
Why?
|
Flounder | 1 | 2002 | 6 | 0.010 |
Why?
|
Receptors, CCR5 | 1 | 2005 | 491 | 0.010 |
Why?
|
Pre-Eclampsia | 1 | 1992 | 1256 | 0.010 |
Why?
|
Spine | 1 | 1989 | 1134 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 16042 | 0.010 |
Why?
|
Electric Stimulation | 1 | 1987 | 1736 | 0.010 |
Why?
|
Plasminogen Activators | 1 | 1982 | 199 | 0.010 |
Why?
|
Mercuric Chloride | 1 | 2001 | 16 | 0.010 |
Why?
|
Lanthanum | 1 | 2001 | 30 | 0.010 |
Why?
|
Charcoal | 1 | 1982 | 67 | 0.010 |
Why?
|
Secretory Rate | 1 | 1981 | 82 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 2004 | 609 | 0.010 |
Why?
|
Intestines | 1 | 2011 | 1904 | 0.010 |
Why?
|
Chromatography, Ion Exchange | 1 | 1982 | 292 | 0.010 |
Why?
|
Electric Conductivity | 1 | 2002 | 405 | 0.010 |
Why?
|
Ranidae | 1 | 2001 | 32 | 0.010 |
Why?
|
Plasmids | 1 | 2007 | 2267 | 0.010 |
Why?
|
Glycoproteins | 1 | 1989 | 2201 | 0.010 |
Why?
|
Chromogranins | 1 | 1982 | 161 | 0.010 |
Why?
|
Seawater | 1 | 2002 | 126 | 0.010 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 1 | 2003 | 184 | 0.010 |
Why?
|
Hypothalamus | 1 | 2007 | 1003 | 0.010 |
Why?
|
Ion Transport | 1 | 2002 | 322 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2004 | 596 | 0.010 |
Why?
|
Nephrocalcinosis | 1 | 2001 | 51 | 0.010 |
Why?
|
Carbachol | 1 | 2001 | 223 | 0.010 |
Why?
|
Sarcoplasmic Reticulum | 1 | 2001 | 164 | 0.010 |
Why?
|
Administration, Oral | 1 | 1989 | 4014 | 0.010 |
Why?
|
Freezing | 2 | 1979 | 310 | 0.010 |
Why?
|
Dimaprit | 1 | 1980 | 6 | 0.010 |
Why?
|
Receptors, Histamine H2 | 1 | 1980 | 18 | 0.010 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2001 | 132 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 5789 | 0.010 |
Why?
|
GTP-Binding Protein Regulators | 1 | 2000 | 12 | 0.010 |
Why?
|
Dopamine Antagonists | 2 | 1983 | 279 | 0.010 |
Why?
|
Infant, Premature | 1 | 1991 | 2121 | 0.010 |
Why?
|
Refrigeration | 1 | 1980 | 27 | 0.010 |
Why?
|
Phospholipase C beta | 1 | 2000 | 48 | 0.010 |
Why?
|
3',5'-Cyclic-GMP Phosphodiesterases | 1 | 1980 | 56 | 0.010 |
Why?
|
Interleukin-8 | 1 | 2004 | 701 | 0.010 |
Why?
|
Tosyl Compounds | 1 | 2001 | 115 | 0.010 |
Why?
|
Thiourea | 1 | 1980 | 68 | 0.010 |
Why?
|
Receptor, Endothelin B | 1 | 2000 | 46 | 0.010 |
Why?
|
Tissue Preservation | 2 | 1979 | 170 | 0.010 |
Why?
|
Magnesium Deficiency | 1 | 2000 | 48 | 0.010 |
Why?
|
Buffers | 1 | 2000 | 141 | 0.010 |
Why?
|
Cyclic GMP | 1 | 1981 | 394 | 0.010 |
Why?
|
Egg Shell | 1 | 2000 | 9 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 1987 | 2002 | 0.010 |
Why?
|
Heterotrimeric GTP-Binding Proteins | 1 | 2000 | 94 | 0.010 |
Why?
|
2',3'-Cyclic-Nucleotide Phosphodiesterases | 1 | 1980 | 6 | 0.010 |
Why?
|
Somatostatin | 1 | 1982 | 459 | 0.010 |
Why?
|
Histamine Antagonists | 1 | 1980 | 93 | 0.010 |
Why?
|
Perfusion | 1 | 1985 | 1409 | 0.010 |
Why?
|
Nonlinear Dynamics | 1 | 2002 | 489 | 0.010 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2000 | 310 | 0.010 |
Why?
|
Temperature | 2 | 1998 | 2229 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2008 | 2869 | 0.010 |
Why?
|
Succinylcholine | 1 | 1979 | 67 | 0.010 |
Why?
|
Glomerular Filtration Rate | 2 | 1998 | 2230 | 0.010 |
Why?
|
Drug Synergism | 1 | 1984 | 1755 | 0.010 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2000 | 148 | 0.010 |
Why?
|
Receptors, Cholinergic | 1 | 1980 | 243 | 0.010 |
Why?
|
Spleen | 1 | 2005 | 2294 | 0.010 |
Why?
|
Iothalamate Meglumine | 1 | 1979 | 9 | 0.010 |
Why?
|
Gestational Age | 2 | 2002 | 3617 | 0.010 |
Why?
|
Immunoglobulins | 1 | 2003 | 853 | 0.010 |
Why?
|
Anti-Infective Agents, Local | 1 | 2001 | 246 | 0.010 |
Why?
|
Echocardiography | 1 | 2012 | 5030 | 0.010 |
Why?
|
Parietal Cells, Gastric | 1 | 1999 | 39 | 0.010 |
Why?
|
Tubulin | 1 | 2003 | 694 | 0.010 |
Why?
|
Coloring Agents | 1 | 2001 | 565 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2012 | 3919 | 0.010 |
Why?
|
Biological Transport, Active | 2 | 1977 | 323 | 0.010 |
Why?
|
Liver | 2 | 2005 | 7570 | 0.010 |
Why?
|
Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1998 | 20 | 0.010 |
Why?
|
Sindbis Virus | 1 | 1998 | 36 | 0.010 |
Why?
|
Mice, SCID | 1 | 2004 | 2626 | 0.010 |
Why?
|
Phosphoinositide Phospholipase C | 1 | 1998 | 29 | 0.010 |
Why?
|
Octoxynol | 1 | 1998 | 76 | 0.010 |
Why?
|
Massage | 1 | 1978 | 84 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2001 | 928 | 0.010 |
Why?
|
Aorta | 1 | 2006 | 2041 | 0.010 |
Why?
|
Cholecystokinin | 1 | 1978 | 114 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 2001 | 746 | 0.010 |
Why?
|
Gastrointestinal Hormones | 1 | 1978 | 101 | 0.010 |
Why?
|
Fetus | 1 | 2005 | 1878 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 2001 | 498 | 0.010 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 1978 | 179 | 0.010 |
Why?
|
Necturus | 1 | 1997 | 14 | 0.010 |
Why?
|
Protein Denaturation | 1 | 1998 | 241 | 0.010 |
Why?
|
Anilides | 1 | 2001 | 413 | 0.010 |
Why?
|
Stroke Volume | 1 | 2012 | 5583 | 0.010 |
Why?
|
Gastric Fundus | 1 | 1997 | 37 | 0.010 |
Why?
|
Lipids | 1 | 1989 | 3319 | 0.010 |
Why?
|
Amiloride | 1 | 1997 | 116 | 0.010 |
Why?
|
Risk Assessment | 2 | 2011 | 24272 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2011 | 39283 | 0.010 |
Why?
|
Pyloric Antrum | 1 | 1997 | 66 | 0.010 |
Why?
|
Osmotic Pressure | 1 | 1978 | 136 | 0.010 |
Why?
|
Baculoviridae | 1 | 1997 | 115 | 0.010 |
Why?
|
Chromaffin Granules | 1 | 1977 | 4 | 0.010 |
Why?
|
Adenosine Triphosphatases | 1 | 2001 | 840 | 0.010 |
Why?
|
Chromaffin System | 1 | 1977 | 15 | 0.010 |
Why?
|
Prolactin | 2 | 1996 | 627 | 0.010 |
Why?
|
Dietary Proteins | 1 | 2002 | 960 | 0.010 |
Why?
|
Loop of Henle | 1 | 1997 | 38 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1998 | 765 | 0.010 |
Why?
|
Xanthines | 1 | 1977 | 121 | 0.010 |
Why?
|
Tunicamycin | 1 | 1997 | 108 | 0.010 |
Why?
|
Protein Subunits | 1 | 2000 | 940 | 0.010 |
Why?
|
Prostatic Hyperplasia | 1 | 2001 | 514 | 0.010 |
Why?
|
Organ Preservation | 1 | 1980 | 400 | 0.010 |
Why?
|
Fluid Therapy | 1 | 2000 | 587 | 0.010 |
Why?
|
Reticulocytes | 1 | 1977 | 287 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2012 | 65202 | 0.010 |
Why?
|
Cricetinae | 1 | 2000 | 2416 | 0.010 |
Why?
|
Renin | 1 | 1999 | 647 | 0.010 |
Why?
|
Cerebellum | 1 | 2004 | 1520 | 0.010 |
Why?
|
Microelectrodes | 1 | 1997 | 305 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2004 | 1647 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2005 | 2060 | 0.010 |
Why?
|
Coculture Techniques | 1 | 2000 | 1336 | 0.010 |
Why?
|
Diabetes Insipidus | 1 | 1997 | 144 | 0.010 |
Why?
|
Urinary Bladder | 1 | 2002 | 1155 | 0.010 |
Why?
|
Benzyl Alcohols | 1 | 1976 | 33 | 0.010 |
Why?
|
Gene Rearrangement | 1 | 2001 | 1142 | 0.010 |
Why?
|
Area Under Curve | 1 | 2000 | 1638 | 0.010 |
Why?
|
Nitriles | 1 | 2001 | 981 | 0.010 |
Why?
|
Lung | 1 | 1994 | 10064 | 0.010 |
Why?
|
Water-Electrolyte Balance | 1 | 1997 | 326 | 0.010 |
Why?
|
Body Water | 1 | 1997 | 337 | 0.010 |
Why?
|
Endoplasmic Reticulum | 1 | 2001 | 1132 | 0.010 |
Why?
|
Cadmium | 1 | 1976 | 218 | 0.010 |
Why?
|
Apoproteins | 1 | 1974 | 45 | 0.010 |
Why?
|
Tetany | 1 | 1994 | 13 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1997 | 780 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2004 | 3424 | 0.010 |
Why?
|
Ribonucleases | 1 | 1995 | 266 | 0.010 |
Why?
|
Dissection | 1 | 1996 | 298 | 0.010 |
Why?
|
Bone Diseases, Developmental | 1 | 1995 | 131 | 0.010 |
Why?
|
Muscle Contraction | 1 | 1979 | 1208 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 2001 | 1776 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2000 | 2511 | 0.010 |
Why?
|
Stomach | 1 | 1999 | 700 | 0.010 |
Why?
|
Tritium | 1 | 1974 | 707 | 0.010 |
Why?
|
Drug Stability | 1 | 1974 | 289 | 0.010 |
Why?
|
Hydrogen | 1 | 1974 | 168 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1974 | 634 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2884 | 0.010 |
Why?
|
Aldosterone | 1 | 1999 | 881 | 0.010 |
Why?
|
Genetic Markers | 1 | 2000 | 2603 | 0.010 |
Why?
|
Immunoblotting | 1 | 1997 | 1646 | 0.010 |
Why?
|
Androgens | 1 | 2001 | 1279 | 0.010 |
Why?
|
Young Adult | 2 | 2010 | 59928 | 0.010 |
Why?
|
Pancreas | 1 | 2000 | 1699 | 0.010 |
Why?
|
Arsenic | 1 | 1976 | 357 | 0.010 |
Why?
|
Emergencies | 1 | 1979 | 1223 | 0.010 |
Why?
|
Medroxyprogesterone | 1 | 1992 | 33 | 0.010 |
Why?
|
Prostate | 1 | 2001 | 1757 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2004 | 3439 | 0.010 |
Why?
|
Bone Marrow | 1 | 2002 | 2926 | 0.010 |
Why?
|
Mast Cells | 1 | 1980 | 1405 | 0.010 |
Why?
|
Chromosome Banding | 1 | 1992 | 261 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2003 | 3508 | 0.010 |
Why?
|
Thyrotropin | 1 | 1996 | 834 | 0.010 |
Why?
|
Androgen Antagonists | 1 | 2001 | 1411 | 0.010 |
Why?
|
Placenta | 1 | 2001 | 1725 | 0.010 |
Why?
|
Medroxyprogesterone Acetate | 1 | 1992 | 153 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2010 | 20129 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2002 | 2901 | 0.010 |
Why?
|
DNA Probes | 1 | 1992 | 541 | 0.010 |
Why?
|
Dexamethasone | 1 | 1999 | 1962 | 0.010 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 1992 | 274 | 0.010 |
Why?
|
Biological Assay | 2 | 1988 | 626 | 0.010 |
Why?
|
Recurrence | 2 | 1980 | 8478 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1992 | 705 | 0.010 |
Why?
|
Myocardium | 1 | 2004 | 4763 | 0.010 |
Why?
|
Species Specificity | 1 | 1995 | 2413 | 0.010 |
Why?
|
Hydrocortisone | 1 | 1999 | 1838 | 0.010 |
Why?
|
Teriparatide | 1 | 1992 | 225 | 0.010 |
Why?
|
Culture Techniques | 1 | 1990 | 529 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1997 | 1457 | 0.010 |
Why?
|
Mannosidases | 1 | 1989 | 21 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2012 | 20706 | 0.010 |
Why?
|
Radiography | 3 | 1992 | 6967 | 0.010 |
Why?
|
Swine | 1 | 1980 | 5981 | 0.010 |
Why?
|
Pregnancy Trimester, Third | 1 | 1992 | 587 | 0.010 |
Why?
|
Diet | 2 | 2000 | 8085 | 0.010 |
Why?
|
Neuraminidase | 1 | 1989 | 192 | 0.010 |
Why?
|
Poly A | 1 | 1989 | 180 | 0.010 |
Why?
|
Flupenthixol | 2 | 1978 | 11 | 0.000 |
Why?
|
Body Weight | 1 | 2000 | 4625 | 0.000 |
Why?
|
Delayed-Action Preparations | 1 | 1992 | 966 | 0.000 |
Why?
|
Mass Spectrometry | 1 | 1976 | 2196 | 0.000 |
Why?
|
Chromatography, Affinity | 1 | 1989 | 524 | 0.000 |
Why?
|
Schizophrenia | 1 | 2007 | 6975 | 0.000 |
Why?
|
Pregnancy Outcome | 1 | 1999 | 2970 | 0.000 |
Why?
|
Immunologic Techniques | 1 | 1988 | 212 | 0.000 |
Why?
|
Random Allocation | 1 | 1992 | 2393 | 0.000 |
Why?
|
Diagnosis, Differential | 3 | 1996 | 12979 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2013 | 59538 | 0.000 |
Why?
|
Lectins | 1 | 1989 | 490 | 0.000 |
Why?
|
Hand | 1 | 1992 | 909 | 0.000 |
Why?
|
Glucose | 1 | 1999 | 4339 | 0.000 |
Why?
|
Gallic Acid | 1 | 1986 | 25 | 0.000 |
Why?
|
Dantrolene | 1 | 1986 | 26 | 0.000 |
Why?
|
Skin | 1 | 2000 | 4498 | 0.000 |
Why?
|
Nifedipine | 1 | 1986 | 220 | 0.000 |
Why?
|
Recombinant Fusion Proteins | 1 | 1994 | 3736 | 0.000 |
Why?
|
Erythrocyte Membrane | 2 | 1977 | 438 | 0.000 |
Why?
|
Protein Kinase Inhibitors | 1 | 1982 | 5696 | 0.000 |
Why?
|
Protons | 1 | 1990 | 1097 | 0.000 |
Why?
|
Dogs | 1 | 1989 | 3834 | 0.000 |
Why?
|
Drug Administration Schedule | 1 | 1992 | 4850 | 0.000 |
Why?
|
Menopause | 1 | 1992 | 1657 | 0.000 |
Why?
|
Beverages | 1 | 1989 | 819 | 0.000 |
Why?
|
Angiography | 2 | 1979 | 1590 | 0.000 |
Why?
|
Radiometry | 1 | 1988 | 812 | 0.000 |
Why?
|
Endocrinology | 1 | 1989 | 441 | 0.000 |
Why?
|
Rats, Inbred Strains | 1 | 1983 | 2078 | 0.000 |
Why?
|
Alprostadil | 1 | 1981 | 86 | 0.000 |
Why?
|
Guanylate Cyclase | 1 | 1981 | 206 | 0.000 |
Why?
|
Prospective Studies | 2 | 1997 | 54826 | 0.000 |
Why?
|
Naproxen | 1 | 1980 | 101 | 0.000 |
Why?
|
Postoperative Complications | 2 | 1981 | 15818 | 0.000 |
Why?
|
Prognosis | 1 | 1980 | 29922 | 0.000 |
Why?
|
Pseudohypoparathyroidism | 1 | 1980 | 87 | 0.000 |
Why?
|
Depression, Chemical | 1 | 1978 | 186 | 0.000 |
Why?
|
Sympathomimetics | 1 | 1977 | 56 | 0.000 |
Why?
|
Dihydrotachysterol | 1 | 1977 | 4 | 0.000 |
Why?
|
Gastrins | 1 | 1977 | 75 | 0.000 |
Why?
|
Isethionic Acid | 1 | 1977 | 4 | 0.000 |
Why?
|
Suramin | 1 | 1977 | 34 | 0.000 |
Why?
|
Phlebography | 1 | 1978 | 326 | 0.000 |
Why?
|
Mediastinum | 1 | 1978 | 272 | 0.000 |
Why?
|
Blood Pressure | 1 | 1992 | 8532 | 0.000 |
Why?
|
Forearm | 1 | 1978 | 425 | 0.000 |
Why?
|
Mediastinal Neoplasms | 1 | 1979 | 403 | 0.000 |
Why?
|
Stilbenes | 1 | 1977 | 154 | 0.000 |
Why?
|
Sulfhydryl Compounds | 1 | 1976 | 296 | 0.000 |
Why?
|
Cold Temperature | 1 | 1979 | 795 | 0.000 |
Why?
|
Neck | 1 | 1978 | 734 | 0.000 |
Why?
|
Pediatrics | 1 | 1989 | 3613 | 0.000 |
Why?
|
Child, Preschool | 1 | 1996 | 42576 | 0.000 |
Why?
|
Catheterization | 1 | 1979 | 1427 | 0.000 |
Why?
|
Bone Diseases | 1 | 1977 | 412 | 0.000 |
Why?
|
Neoplasms, Multiple Primary | 1 | 1977 | 594 | 0.000 |
Why?
|
Blood Proteins | 1 | 1978 | 1192 | 0.000 |
Why?
|
Serotonin | 1 | 1977 | 1045 | 0.000 |
Why?
|
Blood Platelets | 1 | 1977 | 2465 | 0.000 |
Why?
|
United States | 1 | 1989 | 72910 | 0.000 |
Why?
|